Neurons Don’t Simply Inherit Their Identity—They Build It After Birth

A neuron becomes a specific kind of cell not simply because it inherits a fixed program from its parent cell. In a 2026 study of the developing Drosophila visual system, researchers found that neuronal identity is assembled in the period after a neuron is born, as the cell changes which regulatory regions of its DNA are accessible. 910

The study, published online in Proceedings of the National Academy of Sciences on August 19, 2026, provides a detailed look at the regulatory logic behind neuronal differentiation. 110

What the developmental atlas measured

The team mapped 232,251 cells from the fruit fly visual system at four developmental stages. The dataset combined two complementary measurements: mRNA expression, indicating which genes are active, and chromatin accessibility, indicating which DNA regions are open and potentially available to regulate genes. 89

That combination allowed the researchers to predict enhancer regions—noncoding DNA switches that help control gene expression—for differentially expressed genes across roughly 250 cell types. The primary study reports that enhancer use changes extensively during brain development and is unexpectedly specific to particular neuron types. 10

Identity is built after the final cell division

The central result is that a newly born neuron does not merely receive a completed identity from its progenitor. Instead, it undergoes rapid remodeling of chromatin accessibility: some enhancers become available while others close. This creates a regulatory environment in which the neuron can activate the gene program associated with its eventual type. 910

In practical terms, the same genome can support many neuron types because different cells expose different sets of DNA switches at different points in development. The study describes this early post-birth period as a key window for establishing a neuron's long-term identity. 9

The same transcription factors can do different jobs

Transcription factors are proteins that help control genes by acting at regulatory DNA. The study indicates that their role depends on developmental context. Before a cell's final division, transcription factors are involved in progenitor-state programs; after division, combinations of factors act through neuron-specific accessible enhancers to drive specialized differentiation programs. 10

This helps explain why the presence of a transcription factor alone is not enough to predict what kind of neuron a cell will become. Its effect depends on which other factors are present, when they act, and which enhancers are accessible in that cell.

No single master regulator explains neuronal fate

The atlas argues against a simple model in which one universal “master regulator” determines neuronal identity. Instead, neuronal differentiation follows a combinatorial and context-dependent logic: distinct factor combinations act on distinct enhancers in different neuron types. 910

The researchers also report that the same effector gene can be regulated by different transcription-factor combinations through different enhancers in different neurons. 10 That means similar functional outcomes can be reached through different regulatory routes.

Every neuron type has an enhancer fingerprint

A mature neuron type can be described not only by the genes it expresses, but also by its characteristic set of accessible regulatory DNA regions. This accessible-chromatin pattern functions as a molecular fingerprint of the cell’s regulatory potential. 910

That distinction matters because neurons may share many transcription factors or even overlap in gene expression while still maintaining different identities and functions. The enhancer landscape provides an additional layer of specificity.

What this could mean for replacement-neuron research

The findings suggest that generating a desired replacement neuron may require more than activating a few marker genes or introducing one transcription factor. A successful approach may need to reproduce the appropriate sequence of enhancer and chromatin-state changes that occurs during normal development.

This is relevant as a framework for diseases involving neuron loss, including Parkinson’s disease, ALS, and glaucoma. But the study was conducted in the fruit fly visual system and does not demonstrate a human therapy. Its immediate contribution is a more detailed map of how neuronal identities are specified—knowledge that may help guide future regenerative-medicine research. 910